Elizabeth H.z. Thompson
Evp, Head Of Research & Dev at Acadia Pharmaceuticals Inc (ACAD)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $506K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 31SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 16,50819,044 held (−46%) | $26.13 | $431K | -26.8% |
| Jul 31SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 5018,994 held (−0%) | $26.17 | $1K | -26.9% |
| Mar 26SEC | ACADAcadia Pharmaceuticals Inc | Sell Plan | 3,4353,280 held (−51%) | $21.47 | $74K | -10.9% |
- Sell
Evp, Head Of Research & Dev Elizabeth H.z. Thompson sold $431K of ACAD at $26.13 — cuts the stake by 46%; pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of Research & Dev Elizabeth H.z. Thompson sold $1K of ACAD at $26.17 — pre-scheduled 10b5-1 plan sale.
- Sell
Evp, Head Of Research & Dev Elizabeth H.z. Thompson sold $74K of ACAD at $21.47 — cuts the stake by 51%; pre-scheduled 10b5-1 plan sale.